Gene: CBX7
Official Full Name: chromobox 7provided by HGNC
Gene Summary: This gene encodes a protein that contains the CHROMO (CHRomatin Organization MOdifier) domain. The encoded protein is a component of the Polycomb repressive complex 1 (PRC1), and is thought to control the lifespan of several normal human cells. [provided by RefSeq, Oct 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO04248 | CBX7 Knockout cell line (HeLa) | Human | CBX7 | 1:3~1:6 | Negative | Online Inquiry |
KO04249 | CBX7 Knockout cell line (HCT 116) | Human | CBX7 | 1:2~1:4 | Negative | Online Inquiry |
KO04250 | CBX7 Knockout cell line (HEK293) | Human | CBX7 | 1:3~1:6 | Negative | Online Inquiry |
KO04251 | CBX7 Knockout cell line (A549) | Human | CBX7 | 1:3~1:4 | Negative | Online Inquiry |
CBX7 Gene Knockout Cell Lines are meticulously engineered cellular models designed to facilitate the detailed study of the CBX7 gene's role in various biological processes, particularly in cancer biology and epigenetic regulation. These knockout cell lines provide a valuable tool for researchers aiming to investigate the specific functions of CBX7, which is known to be involved in chromatin remodeling, gene expression, and cellular differentiation, often exhibiting implications in tumorigenesis. By completely removing the CBX7 gene, these cell lines enable the assessment of its biological functions and the pathways it influences under controlled laboratory conditions.
The key mechanism of action involves the disruption of a critical component of the PRC1 (Polycomb Repressive Complex 1), which alters chromatin structure and consequently impacts transcriptional regulation. This allows researchers to examine downstream effects on gene expression profiles, cellular proliferation, and apoptosis, among other cellular phenomena. Given the pivotal role of CBX7 in regulating cellular processes, these knockout cell lines are particularly valuable in elucidating mechanisms underlying various diseases, especially cancers, where aberrant regulation of gene expression is a hallmark.
Scientific importance is underscored by the potential applications of CBX7 knockout models in both basic research and translational studies. They can significantly deepen our understanding of epigenetic alterations in cancer and other diseases, paving the way for potential therapeutic strategies that target these pathways.
One of the notable advantages of using our CBX7 Gene Knockout Cell Lines is their specificity and reproducibility in experimental setups. Unlike general inhibitors or chemical agents, these genetically modified lines offer a precise mechanism for dissecting gene function without off-target effects, making results more interpretable and reliable. Furthermore, they are readily adaptable for various assays including CRISPR/Cas9, gene expression analysis, and functional genomics studies, making them highly versatile tools for researchers.
For researchers, clinicians, and biotechnology companies, the access to precise and validated models of gene knockout such as these is invaluable for advancing therapeutic development, understanding disease mechanisms, and conducting high-quality research. Our commitment to providing high-grade, scientifically validated biological products reflects our expertise in the field and our dedication to empowering discoveries that can lead to significant advancements in health and medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.